A Self-Assembled α-Synuclein Nanoscavenger for Parkinson's Disease
A Self-Assembled α-Synuclein Nanoscavenger for Parkinson's Disease
复制标题
用于帕金森病的自组装α-突触核蛋白纳米清除剂
DOI:
10.1021/acsnano.9b06453
复制
发表时间:
2020-02-01
期刊:
影响因子:
17.1
通讯作者:
Liu, Gang
中科院分区:
文献类型:
--
作者:
Liu, Jingyi;Liu, Chao;Liu, Gang
Although emerging evidence suggests that the pathogenesis of Parkinson's disease (PD) is closely related to the aggregation of alpha-synuclein (alpha-syn) in the midbrain, the clearance of alpha-syn remains an unmet clinical need. Here, we develop a simple and efficient strategy for fabricating the alpha-syn nanoscavenger for PD via a reprecipitation self-assembly procedure. The curcumin analogue-based nanoscavenger (NanoCA) is engineered to be capable of a controlled-release property to stimulate nuclear translocation of the major autophagy regulator, transcription factor EB (TFEB), triggering both autophagy and calcium-dependent exosome secretion for the clearance of alpha-syn. Pretreatment of NanoCA protects cell lines and primary neurons from MPP+-induced neurotoxicity. More importantly, a rapid arousal intranasal delivery system (RA-IDDS) was designed and applied for the brain-targeted delivery of NanoCA, which affords robust neuroprotection against behavioral deficits and promotes clearance of monomer, oligomer, and aggregates of alpha-syn in the midbrain of an MPTP mouse model of PD. Our findings provide a clinically translatable therapeutic strategy aimed at neuroprotection and disease modification in PD.